ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DRUG Bright Minds Biosciences Inc

1.22
0.05 (4.27%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Bright Minds Biosciences Financial Summary

The current DRUG market cap is 5.45M. The company's latest EPS is CAD -1.6515 and P/E is -0.73.

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
CAD ($)CAD ($)CAD ($)
Total Revenue 00000
Operating Income -2.09M-1.77M-2.23M-2.24M-1.45M
Net Income -2.34M-2.05M-1.46M-1.53M-1.68M
Year End September 29 2023 202120222023
CAD ($)CAD ($)CAD ($)
Total Revenue 000
Operating Income -7.68M-13.31M-6.56M
Net Income -8.65M-14.97M-7.37M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
CAD ($)CAD ($)CAD ($)
Total Assets 11.55M9.99M8.46M6.88M6.89M
Total Liabilities 583k1.04M735k281k854k
Total Equity 10.97M8.95M7.73M6.6M6.03M
Year End September 29 2023 202120222023
CAD ($)CAD ($)CAD ($)
Total Assets 20.04M12.09M6.88M
Total Liabilities 639k1.54M281k
Total Equity 19.4M10.54M6.6M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
CAD ($)CAD ($)CAD ($)
Operating -2.66M-4.18M-5.83M-7.03M-822k
Investing N/A N/A N/A N/A N/A
Financing 2.26M2.23M2.21M2.19M878k
Year End September 29 2023 202120222023
CAD ($)CAD ($)CAD ($)
Operating -7.32M-13.59M-7.03M
Investing N/A N/A N/A
Financing 26.06M5.2M2.19M
Market Cap 5.45M
Price to Earnings Ratio -0.73
Price to Sales Ratio 0
Price to Cash Ratio 0.79
Price to Book Ratio 0.81
Dividend Yield -

Share Statistics

Shares Outstanding 4.46M
Average Volume (1 week) 29.54k
Average Volume (1 Month) 25.35k
52 Week Change -44.55%
52 Week High 6.44
52 Week Low 1.09
Spread (Intraday) 0.02 (1.64%)

Company Info

Company Name Bright Minds Biosciences Inc
Address 1500 - 1055 west georgia street
vancouver, british columbia V6E 4N7
Website https://www.brightmindsbio.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock